InsidersTradesSigma
Track the Aegerion Pharmaceuticals, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 29 January 2016 (Levée d'options). Among the most active insiders: SMITH SANDFORD D. Every trade is accessible without an account.
Analysts rate Aegerion Pharmaceuticals, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Aegerion Pharmaceuticals, Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades raras. Cotiza en NASDAQ bajo el ticker AEGR.